Morgan Stanley’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.93K | Sell |
380
-462
| -55% | -$3.57K | ﹤0.01% | 7150 |
|
|
2025
Q1 | $5.19K | Buy |
842
+612
| +266% | +$3.77K | ﹤0.01% | 6980 |
|
|
2024
Q4 | $1.17K | Sell |
230
-10
| -4% | -$51 | ﹤0.01% | 7250 |
|
|
2024
Q3 | $1.21K | Buy |
240
+10
| +4% | +$50 | ﹤0.01% | 7203 |
|
|
2024
Q2 | $945 | Buy |
230
+100
| +77% | +$411 | ﹤0.01% | 7161 |
|
|
2024
Q1 | $988 | Sell |
130
-184
| -59% | -$1.4K | ﹤0.01% | 7173 |
|
|
2023
Q4 | $2.62K | Buy |
314
+157
| +100% | +$1.31K | ﹤0.01% | 7103 |
|
|
2023
Q3 | $1.33K | Buy |
157
+30
| +24% | +$254 | ﹤0.01% | 7196 |
|
|
2023
Q2 | $1.21K | Sell |
127
-285
| -69% | -$2.71K | ﹤0.01% | 7273 |
|
|
2023
Q1 | $2.39K | Sell |
412
-67
| -14% | -$389 | ﹤0.01% | 7204 |
|
|
2022
Q4 | $3.89K | Sell |
479
-161
| -25% | -$1.31K | ﹤0.01% | 7215 |
|
|
2022
Q3 | $5K | Sell |
640
-1,086
| -63% | -$8.48K | ﹤0.01% | 7246 |
|
|
2022
Q2 | $20K | Sell |
1,726
-10,797
| -86% | -$125K | ﹤0.01% | 6986 |
|
|
2022
Q1 | $266K | Sell |
12,523
-3,600
| -22% | -$76.5K | ﹤0.01% | 5764 |
|
|
2021
Q4 | $468K | Buy |
16,123
+12,178
| +309% | +$353K | ﹤0.01% | 5594 |
|
|
2021
Q3 | $385K | Buy |
3,945
+1,205
| +44% | +$118K | ﹤0.01% | 5651 |
|
|
2021
Q2 | $357K | Buy |
2,740
+2,645
| +2,784% | +$345K | ﹤0.01% | 5720 |
|
|
2021
Q1 | $17K | Buy |
+95
| New | +$17K | ﹤0.01% | 6776 |
|